carbazilquinone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takenaka, T | 1 |
Maruyama, K | 1 |
Kinoshita, T | 1 |
Sasako, M | 1 |
Sano, T | 1 |
Katai, H | 1 |
Matsuno, Y | 1 |
Sampi, K | 1 |
Masaoka, T | 1 |
Takagi, T | 1 |
Sakamoto, S | 1 |
Mikuni, C | 1 |
Kano, Y | 1 |
2 trials available for carbazilquinone and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Che | 1997 |
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resi | 1989 |